FDA inspection
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC: FDA inspection ending Sep 19, 2023
FDA inspection 1218069 · Voluntary Action Indicated (VAI) · Andover, MA
Key facts
| Inspection ID | 1218069 |
|---|---|
| Firm | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC |
| FEI number | 1222181 |
| Address | 1 Burtt Rd |
| City | Andover |
| State | MA |
| ZIP | 01810 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Sep 19, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data